Kaplan–Meier survival analysis indicated that the 5-year overall survival rate of patients with high CD3D expression in tumor tissues was 57.4%, while that of patients with low CD3D expression was 46.1%, showing a significant difference (Figure 1C, P=0.006). This evidence concerns the gene CD3D and neoplasm.